June 17, 2019 Comments Off on Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements Posted in: Insights This paper was originally published by Ingrid Freije, Stéphane Lamouche, and Mario Tanguay in Therapeutic Innovation & Regulatory Science under a Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/…
June 10, 2019 Comments Off on Generic Drug Market Entry in Europe: Why a Tailored Approach Is Best Posted in: Uncategorized
Generic drug makers must tailor European market entry strategies to each country. Moreover, they must address the sequence in which they want to enter markets.
The post Generic Drug Market Entry in Europe: Why a Tailored Approach Is Best appeared first…
